On the other hand, URB447 – a synthetic cannabinoid ligand acting as a CB2 agonist and CB1 antagonist reduced cell viability of melanoma leading to G0/G1 cell cycle arrest accompanied by a decrease in S-phase cell counts [31]. This evidence concerns the gene CNR1 and melanoma.